Canisius Wilhelmina Ziekenhuis — Clinical Trial Site

95 Registered trials

42 Currently recruiting

Organisation

Canisius Wilhelmina Ziekenhuis

Location

Nijmegen, Netherlands

Identifier

ORG-100029366

Address

Weg Door Jonkerbos 100, 6532 SZ, Netherlands

Departments

#2203; urology
#2908:Internal Medicine
#3703: Cardiology
2616:Internal Medicine
5003; Nuclear Medicine
Canisius Wilhelmina Ziekenhuis
Cardiology
Cardiology Department
chirurgie
Department of Medical Oncology
Department of Pulmonary Medicine
gastroenterology
Gynaecology
Hematology
Hematology/Oncology
ICU
ICU, B44
Intensive Care
Intensive care unit
Internal Medicine
Interne Geneeskunde
Medical Oncology
Medische Oncologie
N/A
Neurologie
Neurology
Neurosurgery
Obstetrics & Gynecology
Oncologie
Oncology
Oncology-Hematology
Orthopaedics
Pediatrics
Pneumology
poli neurologie
Pulmonary Science
Pulmonology
Reproductive Medicine and gynaecology
Research Cardiologie
Research cardiology
Research Faculty
Respiratory Diseases
Urologie
Urology

Clinical trials at this site (95)

Search interface

A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (… Recruiting

2023-510294-34-00 small lymphocytic lymphoma (SLL) 5 2025-06-12
Treatment of ELectroencephalographic STatus epilepticus After cardiopulmonary Resuscitation-2 (TELSTAR-2): a multicenter randomised clinical… Recruiting

2024-516068-27-01 cardiopulmonary resuscitation 5 2025-04-10
Efficacy and safety of minidosing lysergic acid diethylamide (LSD) for chronic cluster headache: a randomized placebo-controlled study Recruiting

2024-520305-39-00 Chronic cluster headache 4 2025-04-01
C2321003: A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men with Metastatic Castration-Resistant… Recruiting

2024-511652-40-00 METASTATIC CASTRATION RESISTANT PROSTATE CANCER 5 2025-02-05
Colchicine for the treatment of hip and knee osteoarthritis. Recruiting

2024-511359-16-00 Osteoarthritis 5 2025-01-17
A WORLD-WIDE CLINICAL STUDY TO FIND OUT IF INTRAVENOUS RECOMBINANT HUMAN PLASMA GELSOLIN IS SAFE AND IS BENEFICIAL FOR TREATING ACUTE RESPIR… Recruiting

2023-510109-16-00 Acute Respiratory Distress Syndrome (ARDS) Due to Pneum 4 2025-01-06
Factors Determining the Efficacy of Botulinum Toxin for Arm Tremor in Dystonia: An Exploratory Study Recruiting

2024-515970-28-00 Dystonic tremor syndrome 6 2024-12-20
Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial Recruiting

2024-513092-40-00 Stroke 6 2024-12-05
The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlle… Recruiting

2024-514055-15-00 Pulmonary sarcoidosis 6 2024-11-19
CHASIT Recruiting

2024-516940-24-00 locally advanced urothelial cancer. 4 2024-10-29
DAROTAXEL Recruiting

2024-516939-28-00 metastatic castration-resistant prostate cancer 4 2024-10-28
DOSAgE study: A multicenter randomized phase III trial of DOSe-reduced Chemotherapy for Advanced Colorectal Cancer in Older patients Recruiting

2023-506115-17-00 Metastatic Colorectal Cancer 5 2024-10-14
Tranexamic acid to prevent OpeRation in Chronic subdural Hematoma (TORCH) Recruiting

2024-514927-40-02 Chronic Subdural Hematoma 11 2024-10-01
Dose tapering and Early Discontinuation to InCreAse cosT-effictIveness Of immunotherapy for Non-small cell lung carcinoma trial number 1 (NV… Recruiting

2024-516195-15-00 Advanced NSCLC 5 2024-09-10
HOVON 170 DLBCL: ANTICIPATE: Prevention of ANThracycline-Induced Cardiac dysfunction by dexrazoxane In PATients with diffusE large B-cell ly… Recruiting

2023-505377-32-00 Diffuse large B-cell lymphoma (DLBCL) 5 2024-08-15
FeAsiBility of a treatment free interval in newly diagnosed mUltiple myeLOma patients treated with DaratumUmab-Lenalidomide-DexamethaSone – … Recruiting

2023-508586-33-00 multiple myeloma 5 2024-05-14
VulVaccin study Recruiting

2023-506792-94-00 Vulvar High-Grade Squamous Intraepithelial Lesion (vHSI 11 2024-03-04
Shortened 12 months duration of androgen receptor signalling agent in combination with androgen deprivation therapy in patients with low-vol… Recruiting

2023-506698-36-00 low-volume metastatic castration-sensitive prostate can 5 2024-02-02
A study to investigate the effect of adding cobicistat to venetoclax and azacitidine in patients with acute myeloid leukemia (AML) who are i… Recruiting

2023-505379-61-00 Acute Myeloid Leukaemia 4 2024-01-17
PEHAB II Recruiting

2023-507466-40-00 Prostate cancer 6 2024-01-12
Pancreatitis and early omega-3-fatty acid infusion for reduction of organ failure and mortality. Recruiting

2023-505220-57-03 Predicted severe acute pancreatitis 5 2022-05-09
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) ( MOVE-Lp(a) ) Ended

2025-521067-13-00 Atherosclerotic Cardiovascular Disease (ASCVD) 5 2026-04-24
Phase 2b Clinical Study Evaluating Efficacy and Safety of TAR-200 in Combination with Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Part… Ended

2023-506146-23-00 Non-Muscle-Invasive Urothelial Carcinoma (NMIBC) of the 4 2025-11-17